These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 8621907)

  • 21. Macrophages as accessory cells for class I MHC-restricted immune responses.
    Debrick JE; Campbell PA; Staerz UD
    J Immunol; 1991 Nov; 147(9):2846-51. PubMed ID: 1833459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway.
    Garg N; Nunes MP; Tarleton RL
    J Immunol; 1997 Apr; 158(7):3293-302. PubMed ID: 9120286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
    Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
    J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
    Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses.
    Golding H; Singer A
    J Immunol; 1984 Aug; 133(2):597-605. PubMed ID: 6203969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
    Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
    J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymocyte antigens do not induce tolerance in the CD4+ T cell compartment.
    Jhaver KG; Chandler P; Simpson E; Mellor AL
    J Immunol; 1999 Nov; 163(9):4851-8. PubMed ID: 10528186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.
    Agadjanyan MG; Kim JJ; Trivedi N; Wilson DM; Monzavi-Karbassi B; Morrison LD; Nottingham LK; Dentchev T; Tsai A; Dang K; Chalian AA; Maldonado MA; Williams WV; Weiner DB
    J Immunol; 1999 Mar; 162(6):3417-27. PubMed ID: 10092797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
    Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
    Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation.
    Krasteva M; Kehren J; Horand F; Akiba H; Choquet G; Ducluzeau MT; Tédone R; Garrigue JL; Kaiserlian D; Nicolas JF
    J Immunol; 1998 Feb; 160(3):1181-90. PubMed ID: 9570532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors.
    Schirmbeck R; Böhm W; Reimann J
    J Immunol; 1996 Oct; 157(8):3550-8. PubMed ID: 8871655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition of MHC class I allodeterminants regulates the generation of MHC class II-specific CTL.
    McCarthy SA; Singer A
    J Immunol; 1986 Nov; 137(10):3087-92. PubMed ID: 3095422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses.
    Wang M; Ellison CA; Gartner JG; HayGlass KT
    J Immunol; 1998 Feb; 160(3):1098-105. PubMed ID: 9570522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells.
    Ke Y; Kapp JA
    J Immunol; 1996 Feb; 156(3):916-21. PubMed ID: 8558017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Programming of CTL with heat-killed Brucella abortus and antigen allows soluble antigen alone to generate effective secondary CTL.
    Inoue S; Golding B; Scott D
    Vaccine; 2005 Feb; 23(14):1730-8. PubMed ID: 15705479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo priming of mouse CTL precursors directed to product of a newly defined minor H-42 locus is under a novel control of class II MHC gene.
    Ishikawa H; Suzuki H; Hino T; Kubota E; Saito K
    J Immunol; 1985 Dec; 135(6):3681-5. PubMed ID: 3934264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
    Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
    J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.